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Zn2 is an important cofactor for insulin biosynthesis and
storage in pancreatic -cells. Correspondingly, polymorphisms
in the SLC30A8 gene, encoding the secretory granule Zn2
transporterZnT8, are associatedwith type 2diabetes risk.Using
a genetically engineered (FRET)-based sensor (eCALWY-4), we
showhere that elevated glucose time-dependently increases free
cytosolic Zn2 ([Zn2]cyt) in mouse pancreatic -cells. These
changes become highly significant (853 96 pM versus 452 42
pM, p < 0.001) after 24 h and are associated with increased
expression of the Zn2 importer family members Slc39a6,
Slc39a7, and Slc39a8, and decreased expression of metallothio-
nein 1 and 2. Arguing that altered expression of the above genes
is not due to altered [Zn2]cyt, elevation of extracellular (and
intracellular) [Zn2] failed to mimic the effects of high glucose.
By contrast, increases in intracellular cAMP prompted by
3-isobutyl-1-methylxanthine and forskolin partially mimicked
the effects of glucose onmetallothionein, althoughnotZiP, gene
expression. Modulation of intracellular Ca2 and insulin secre-
tion with pharmacological agents (tolbutamide and diazoxide)
suggested a possible role for changes in these parameters in the
regulation of Slc39a6 and Slc39a7 but not Slc39a8, normetallo-
thionein expression. In summary, 1) glucose induces increases
in [Zn2]cyt, which are then likely to facilitate the processing
and/or the storage of insulin and its cocrystallizationwith Zn2,
and 2) these increases are associated with elevated expression of
zinc importers. Conversely, a chronic increase in [Zn2]cyt fol-
lowing sustained hyperglycemia may contribute to -cell dys-
function and death in some forms of diabetes.
The total Zn2 content of the mammalian pancreas is high,
and these ions are chiefly localized to the islet -cell (1). Corre-
spondingly, Zn2 plays an important role in both insulin syn-
thesis and storage (2–3). Indeed, total Zn2 concentrations
reachmillimolar levels in the interior of the dense-core granule
(4), where two Zn2 ions coordinate six insulin monomers to
form the hexameric structure on which insulin crystals are
based (5). The physiological importance of Zn2 homeostasis
within the -cell in man has been emphasized recently by the
finding that a non-synonymous polymorphism (rs13266634
C/T) in the SLC30A8 gene, encoding the largely pancreatic,
endocrine-restricted, granular zinc transporter ZnT8, is asso-
ciated with an increased risk of type 2 diabetes (T2D)2 (6–9).
Through the generation of mice bearing null alleles, we (10–
11) and others (12) have shown previously that the absence
of ZnT8 leads to the formation of amorphous -cell secre-
tory granules and mild glucose intolerance, consistent with a
role for abnormal -cell Zn2 homeostasis in the pathogen-
esis of T2D (10–12).
A link between the zinc status of the body and diabetes has
been known formany years (1). Several reports have shown that
T2D patients display a marked decrease in total plasma Zn2
and hyperzincuria compared with control subjects (13), sug-
gesting the possibility that hyperglycemia may interfere with
Zn2 absorption in the kidney. Despite the consistent decrease
in plasma Zn2 observed across studies, the levels (total and
free) of the ion within tissues (including muscle, kidney, and
liver) are controversial (14–15). Reduced pancreatic Zn2 has
also been reported in a genetic model of T2D (16–18). How-
ever, no differences in the ultrastructural localization of Zn2
were noted in -cells from rats with monogenic (fa/fa Zucker)
or more complex polygenic (Goto-Kakizaki) forms of diabetes
(19).
Relatively little is known about how Zn2 homeostasis is
achieved in pancreatic -cells and whether, and under what
circumstances, changes in cytosolic Zn2 ([Zn2]cyt) may
occur in these cells. When measured with a synthetic, intracel-
lularly trappable probe (Zinquin), values for free [Zn2]
recorded from whole pancreatic islets were decreased after
infusion of high glucose (20). However, the subcellular localiza-
tion of this particular probe (and others of the same class) (21)
is unclear, as it tends to compartmentalize to undefined gran-
ular structures (11). The above findings (20) are thus difficult to
interpret in terms of the alterations that may occur at the
molecular level to perturb intracellular Zn2 homeostasis as
glucose concentrations increase.
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Using a newly developed, genetically encoded FRET-based
probe (eCALWY-4), we have recently measured free [Zn2]cyt
in the -cell line INS-1 (832/13) and found that it is buffered at
400 pM at low glucose concentrations (22). To tightly maintain
this low free level of Zn2,  and other cell types deploy a vari-
ety of mechanisms, including zinc transporters and binding
proteins (23). There are twomain classes of Zn2 transporters.
The ZnT family (coded by the Slc30a1–10 genes) is thought to
move the ion from the cytosol to intracellular compartments or
into the extracellular space (24). The ZiP (Zrt- and Irt-like pro-
teins) family (coded by the Slc39a1–14 genes), on the other
hand, is responsible for increases in cytosolic Zn2 (25). Evi-
dence for the expression of these transporters in the pancreas is
quite limited, although most studies agree on the fact that
Slc39a6 and Slc39a7, among the Zips, and Slc30a5 and Slc30a8,
among the ZnTs, are the most abundant transporters in pan-
creatic islets (26–27), with other evidence suggesting that
ZnT1 and ZnT4–9 are also additionally expressed (11, 28).
Importantly, Zn2 can also be transported into -cells via volt-
age-gated L-type Ca2 channels (29) opened upon glucose-in-
duced depolarization of the plasma membrane (30).
Metallothioneins (Mt) are redox-active Zn2 binding pro-
teins with a dual function, playing a role in both Zn2 homeo-
stasis and in the regulation of the cellular redox state. In the
latter context, these proteins release Zn2 in response to oxi-
dative damage (31), a condition often found in the tissues of
T2D patients, probably reflecting chronic hyperglycemia (32).
The expression in the -cell of the above array of proteins
involved in Zn2 homeostasis argues for the importance of
tight control of cytosolic Zn2 levels. Indeed, Zn2 plays a role
not only in the defense of  and other cells against oxidative
damage (as part of the CuZn superoxide dismutase (33) and
metallothioneins (34)), but may mediate apoptosis if the free
concentrations of the ion decrease or increase above a safe set-
point (35–36).
In the present studywe show firstly, by imaging free [Zn2]cyt
in primary -cells with eCALWY-4 (22), that glucose is able to
induce a stable increase in the cytosolic concentration of these
ions. Secondly, we show that high glucose leads to profound
alterations in the expression of genes important for Zn2
homeostasis in -cells and explore the signaling mechanisms
involved.
EXPERIMENTAL PROCEDURES
Animals—CD1micewere housedwith fivemice per cage in a
pathogen-free facility and were fed ad libitum with a standard
mouse chow diet. Female mice were used at 10–12 week of age
and were sacrificed by cervical dislocation as approved by the
United Kingdom Home Office Animal Scientific Procedures
Act, 1986.
Reagents—RPMI medium was obtained from Sigma. TRIzol
reagent was from Invitrogen. ZnCl2, forskolin, 3-isobutyl-1-
methylxanthine, tolbutamide,diazoxide,verapamil,N,N,N,N-
tetrakis(2-pyridylmethyl) ethylenediamine (TPEN), and 2-
mercaptopyridine N-oxide (pyrithione) were from Sigma.
Islet Isolation and Dissociation into Single Cells—Pancreatic
mouse islets were prepared as described elsewhere (37). The
islets were allowed to recover overnight in culture medium
(RPMI supplemented with 10% (v/v) heat-inactivated FCS, 2
mM glutamine, 100 units/ml penicillin, and 100 units/ml strep-
tomycin). Islets were dissociated by 10-min incubation in
Hanks’-based enzyme-free cell dissociation buffer (GIBCO,
Invitrogen), before centrifugation and gentle pipetting (37).
Dissociated cells were plated onto 24-mm sterile coverslips and
allowed to recover overnight.
Generation of eCALWY-4-expressing Adenovirus and Infec-
tion of Primary Cells—eCALWY-4 and eCALWY-NB (non-
binding) fragments (22) were PCR-amplified (forward,
CTCGAGCGCCACCATGGGCCATAT; reverse, TCTAGA-
GGCCGCTTTACTTGTACAGCT) and cloned into the
pCR2.1-TA vector (Invitrogen). The fragments were excised
and cloned into plasmid pShuttle usingXho1/Xba1. Adenoviral
constructs were generated as described elsewhere (38). Briefly,
pShuttle-eCALWY constructs were digested with Pme1 and
electroporated into competent BJ5183-AD-1 cells. Recom-
bined pADeasy1 cloneswere screened, and positive cloneswere
then digested with Pac1 and transfected into HEK293 cells for
the generation of adenoviral particles. Primary islet cells were
infected with eCALWY-4-expressing adenovirus (20–25 mul-
tiplicity of infection) for 4 h. The medium was then changed,
and cells were allowed to express the protein for 48 h before
imaging. Either 2 or 24 h before imaging, cells were incubated
with different concentrations of glucose. These cultures typi-
cally contained 70–80%-cells (39–40), andwe confirmed the
identity of individual -cells by confocal microscopy (see Fig.
1B) in a limited number of experiments. Briefly, after infection
with eCALWY-4-expressing adenovirus, primary cells were
fixed in 3.7% paraformaldehyde and permeabilized in 0.1% Tri-
ton X-100 before immunostaining with a polyclonal anti-swine
insulin antibody (1:200, DakoCytomation, Ely, UK) and an
Alexa Fluor 568-coupled secondary antibody. Confocal imag-
ing was performed as described elsewhere (40).
Imaging Free Cytosolic Zn2—Cells were washed twice in
KrebsHepes-bicarbonate buffer (140mMNaCl, 3.6mMKCl, 0.5
mMNaH2PO4, 0.2mMMgSO4, 1.5mMCaCl2, 10mMHepes (pH
7.4), 2 mM NaHCO3), preequilibrated with 95:5 O2:CO2 and
containing either 3 or 16.7 mM glucose. Zn2 imaging was car-
ried out as described by Vinkenborg et al. (22). Briefly, dissoci-
ated islet cells weremaintained at 37 °C throughoutwith a heat-
ing stage (MC60, LINKAM, Scientific Instruments, Surrey,
UK), and Krebs Hepes-bicarbonate buffer was perifused (1
ml/min) with additions as stated in Fig. 1C. 50 M TPEN and 5
M pyrithione were freshly prepared on each day of the exper-
iments. Images were captured using an Olympus IX-70 wide-
field microscope with a 40 oil immersion objective and an
Imago charge-coupled device camera (Till Photonics, Grafelf-
ing, Germany) controlled by TILLvisION software (Till Photo-
nics). For FRET measurements, a 455DRLP dichroic mirror
(Chroma Technology) and two emission filters (Chroma Tech-
nology, D465/30 for cerulean and D535/30 for citrine), alter-
nated by a filter changer (Lambda 10–2, Sutter Instruments),
were used. Images were acquired at 1 Hz using a 100-ms expo-
sure time and a 433-nm excitation wavelength. The fluores-
cence emission ratios were derived after subtracting back-
ground and calibrated for [Zn2]cyt as described under
“Results.”
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RNA Extraction and Quantitative Real-time PCR—For RNA
extraction, 100 islets were incubated for 1 h in RPMI (20 islets/
ml) containing 3mM glucose and subsequently transferred into
a 60-mm Petri dish with culture medium containing either 3 or
16.7mMglucose. Total RNAwas obtained usingTRIzol reagent
(Invitrogen) and treated with a DNA-free kit (Applied Biosys-
tems, Warrington, UK). Total RNA was then reverse-tran-
scribed into cDNA using a high-capacity cDNA reverse tran-
scription kit (Applied Biosystems). cDNA (equivalent to 30 ng
of RNA) was subject to quantitative real-time PCR using Power
SYBR Green master mix (Applied Biosystems) in a 7500 fast
real-time PCR system (ABI Biosystems) and analyzed by the
comparative CT method. All real-time primers (supplemental
Table 1) were generated using ABI Primer Express 3.0 software
and were validated for specificity by dissociation curve (40).
Protein Extraction and Western Blotting (Immunoblotting)
Analysis—For protein analysis, 250 (20 islets/ml of medium)
islets were incubated for 1 h in RPMI containing 3 mM glucose
before a further 24-h incubation with either 3 or 16.7 mM glu-
cose. Islets were then washed twice in ice-cold PBS and lysed in
ice-cold radioimmune precipitation assay buffer (50 mM Tris
HCl (pH 8.0),150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS) before sonication. Proteinwas assayed
with a BCA kit (Pierce). Total protein extracts (30 g) were
resolved by SDS-PAGE (12% v/v acrylamide) and transferred to
PVDF membranes, followed by immunoblotting with rabbit
polyclonal anti mLIV-1 (ZiP6) and anti mKE4 (ZiP7, both used
1:200, Ref. 41), mouse monoclonal anti-metallothioneins
(1:500, Abcam), and mouse monoclonal anti-tubulin (1:5000,
Sigma clone B-5-1-2) antibodies. Secondary HRP-linked anti-
rabbit antibodies (1:10000, GE Healthcare) were revealed by
using ECL detection reagent (GE Healthcare). The intensity of
the bands was quantified using ImageJ software, and the ratio
between the intensity of target proteins and tubulin was
determined.
Bioinformatic and Statistical Analysis—The promoter re-
gions (-3000 to1 bp upstream of the starting codon) of iden-
tified glucose-responsive genes were scanned and analyzed
using Transcription Element Search System (TESS) software.
Statistical significance was assessed by one or two-way analysis
of variance or Student’s two tailed t test with Bonferroni cor-
rection for multiple testing using GraphPad Prism and Excel
software.
RESULTS
Elevated Glucose Promotes a Stable Increase in Cytosolic Free
Zn2Concentrations in Primary-Cells—Monitoring intracel-
lular free Zn2 in primary -cells has so far only been achieved
using synthetic chemical probes (11, 20). These sensors, how-
ever, suffer from limitations, such as a variable extent of com-
partmentalization into intracellular organelles, confounding
both the measurements and their calibration. By generating an
adenoviral expression construct based on our newly developed
FRET-based Zn2 probe, eCALWY-4 (22), wemonitored cyto-
solic Zn2 variations in primary -cells and examined the time
frames over which changes occurred. The ratio of citrine to
cerulean emission (Fig. 1A) was plotted against time (C), and
the minimum and maximum ratios were used to calculate the
free [Zn2]cyt using the following formula: [Zn2]  Kd 
(Rmax-R)/(R-Rmin), where the Kd for eCALWY-4 is 630 pM,
Rmax represents themaximum fluorescence ratio (upon TPEN-
mediated Zn2 chelation), and Rmin is the minimum
fluorescence ratio (obtainedwith 100MZnCl2 in the presence
of the Zn2 ionophore, pyrithione, Ref. 22). Addition of TPEN
or Zn2-pyrithione did not affect the ratio of a non-binding
sensor variant (Fig. 1D). Cells were incubated for 1 h at 3 mM
glucose before application of medium containing either 3 or
16.7mM glucose for 2 or 24 h. The free [Zn2]cyt was calculated
by averaging the concentration of the ion 1 min before applica-
tion of TPEN. After 24 h of treatment, cells incubated at 16.7
mM glucose displayed a substantial and significant (p  0.001)
[Zn2]cyt increase (853 96 pM) comparedwith cells incubated
at 3 mM glucose (452  42 pM) (Fig. 1F). Although cytosolic
Zn2 concentrationswere not significantly different after 2 h of
incubation at high versus low glucose, a tendency toward an
increase in the former case was observed (587 101 pM at 16.7
mM glucose versus 496  60 pM for cells incubated at 3 mM
glucose, p  0.431) (Fig. 1E), indicative of a time-dependent
increase in [Zn2]cyt in response to high glucose.
Regulation byGlucose ofGenes Involved inZn2Homeostasis—
We hypothesized that the above variations in [Zn2]cyt may, at
least in part, reflect changes in the expression of genes known to
regulate Zn2 homeostasis in other cell types, namely ZiPs,
ZnTs, andMt. Thus, wemeasured the relative expression of the
knownmouseZiPs (Slc39a), ZnT (Slc30a), andmetallothionein
(Mt) genes in pancreatic islets at varying glucose concentra-
tions and at two time points. Firstly, after 1-h incubation at 3
mM glucose, mouse islets were cultured in medium supple-
mented with either 3 or 16.7 mM glucose for 24 h. Culture with
16.7 versus 3mM glucose led to a significant increase in Slc39a6
(2.4-fold), Slc39a7 (2.4-fold), and Slc39a8 (6.8-fold)mRNA lev-
els but a decrease in Mt-1 (3.2-fold) and Mt-2 (4-fold) gene
expression (Fig. 2A). The change in ZiP6 expression was also
significantly reflected at the protein level, as demonstrated by
Western blotting (immunoblotting) analysis (Fig. 3). ZiP7 pro-
tein expression showed a tendency to increase in response to
high glucose (Fig. 3A), although the difference was very small
and did not reach significance (B). We were unable to perform
immunoblot analysis on ZiP7 because of the lack of a specific
antibody against the mouse protein. Immunoblot analysis of
metallothioneins revealed no difference at high versus low glu-
cose concentrations (data not shown). In contrast, no changes
in mRNA levels were observed in the expression of any of the
tested Slc30a (ZnT) family members in response to variations
in glucose concentration (Fig. 2A).
To test whether the changes in cytosolic free Zn2
observed (Fig. 1F) upon high glucose challenge were the con-
sequence or the cause of the above changes in gene expres-
sion (Fig. 2A), further qPCR analyses were performed after
2 h of treatment (well before the [Zn2]cyt increase reached
statistically significant level (Fig. 1E)). This analysis was
restricted to the genes that showed a difference when treated
with high versus low glucose after 24 h. Significant changes
of between 1.8- and 2.1-fold were observed at this earlier
time point in Slc39a7 and Mt-2 expression, respectively,
whereas both Slc39a6 and Slc39a8 showed a tendency to
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increase (and Mt-1 to decrease) at 16.7 versus 3 mM glucose
(Fig. 2B).
The above findings suggested that the glucose-induced
variations in gene expression were more likely to contribute
to, rather than be the consequences of, changes in [Zn2]cyt.
To further explore this hypothesis, we exposed pancreatic
islets to medium containing different glucose concentra-
tions (as above), supplemented or not with 50 M ZnCl2 for
24 h, to increase intracellular free Zn2. To confirm that the
concentration of extracellularly applied ZnCl2 was indeed
able to induce an increase in intracellular free Zn2, even in
the absence of high glucose, we measured [Zn2]cyt after
incubation of dissociated islets with 3 mM glucose in the
presence of 50 M ZnCl2 for 24 h. As shown in Fig. 4A,
extracellular ZnCl2 elevated free [Zn2]cyt to a level compa-
rable with that observed after incubation at high glucose
concentrations (903 89 pM versus 855 138 pM). As antic-
ipated (42), ZnCl2 supplementation strongly induced the
metallothionein genes while decreasing the expression of the
Slc39a genes tested (Fig. 4B). Thus, the increase in cytosolic
free Zn2 observed after 24 h of incubation with 16.7 mM
glucose would appear likely to be a consequence of the
changes in the expression of genes involved in controlling
intracellular Zn2 fluxes and binding.
Effect of L-type Voltage-gated Ca2 Channel (VGCC) Inhi-
bition on Glucose-mediated [Zn2]cyt Increase—It is known
that influx of Zn2 from the extracellular space can be medi-
ated by voltage-gated Ca2 channels, opened after glucose
entry has caused KATP channels closure and membrane
depolarization (29). To test whether the increase of [Zn2]cyt
reported here was via the glucose-induced opening of
VGCCs, we measured intracellular Zn2 levels after dissoci-
ated islets were exposed for 24 h to 16.7 mM glucose alone or
with the addition of 20M verapamil, a concentration known
to block the VGCCs in pancreatic -cells (43). Despite the
presence of the VGCC blocker, high glucose concentrations
were still able to induce an increase in free [Zn2]cyt to levels
comparable with that found in the presence of 16.7 mM glu-
cose alone (923 137 pM for verapamil versus 855 138 pM
for the control condition, Fig. 5), suggesting that L-type
Ca2 channels do not play a pivotal role in the rise of cyto-
solic Zn2 (Fig. 5).
FIGURE 1. Imaging the effect of elevated glucose on [Zn2]cyt with eCALWY-4 in primarymouse-cells. A, CD1mouse islets were dissociated into single
cells or clusters of cells, infected with eCALWY-4-expressing adenovirus, and plated on 24-mm coverslips. Cells were imaged with an Olympus IX microscope
and excited at 433 nm, and the emission was recorded at 465 nm and 535 nm for cerulean and citrine, respectively (22). B, partially dissociated mouse islets
seeded on converslips, were infected with eCALWY-4-expressing adenovirus, formaldehyde-fixed, permeabilized, and immunostained with anti-insulin anti-
body andAlexa Fluor 568-coupled secondary antibody,whereasDAPIwas used for nuclear staining. Cell clusters containing insulin-positive cellswere imaged
by confocal microscopy. Scale bar 10m. C, representative trace showing the changes in fluorescence ratio of a cell infected with eCALWY-4 adenovirus or
eCALWY-nonbinding (D) and perifused with the indicated solutions. KRB, Krebs-Ringer buffer; TPEN, 50M; ZnPyr, 5M pyrithione plus 100M ZnCl2. E and F,
analysis of free [Zn2]cyt concentration after 2 and 24 h, respectively, of high glucose treatment. Bars representmean S.E. Number of cell imaged (n) on three
different days of experiments is given in brackets under each bar. ***, p 0.001.
Glucose Regulates Cytosolic Zn2Homeostasis in-Cells
JULY 22, 2011•VOLUME 286•NUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 25781
 at Im
perial College London on N
ovem
ber 6, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Regulation of Slc39a6, Slc39a7, and Slc39a8, and Mt-1 and
Mt-22, by Intracellular cAMP—To examine the potential sig-
naling mechanisms responsible for glucose-evoked changes in
gene expression, we first investigated whether increased cAMP
levels, normally elevated in-cells exposed to high glucose con-
centrations (44–46), might mimic the effect of the sugar. Sug-
gesting this as a possibility, in silico examination of the mouse
Slc39a6, Slc39a7, Slc39a8,Mt-1, andMt-2 genes revealed con-
sensus binding sites for the cAMP responsive element binding
protein (47) in the promoter regions of all the genes examined,
with the exception of Mt-2 (supplemental Table 2). Accord-
ingly, pancreatic islets were incubated in 3, 10, or 16.7 mM
glucose in the presence or absence of the adenylate cyclase acti-
vator forskolin and the phosphodiesterase inhibitor 3-isobutyl-
1-methylxanthine (Fig. 6). Metallothionein expression was
negatively modulated by elevation in cytosolic cAMP concen-
trations at 3 mM glucose, mimicking the effect of high glucose.
Correspondingly, a cAMP responsive element binding protein
consensus binding site was apparent in the Mt-1 promoter
(supplemental Table 2). The Mt-2 promoter, however, con-
tained no such site, indicating that cAMP elevation might act
via other mechanisms than those involving the cAMP respon-
sive element binding protein. By contrast, elevated glucose
(16.7 mM), in combination with increased cAMP, tended to
decrease the expression of the Slc39a genes examined, a trend
that was significant in the case of Slc39a7. At low glucose con-
centrations, on the other hand, cAMP elevations failed to
increase Slc39a6–8 gene expression (Fig. 6). Thus, increases in
intracellular cAMP appear unlikely to explain the enhanced
expression of Slc39a6, Slc39a7, and Slc39a8 in response to high
glucose.
Effect of Sulfonylureas and Diazoxide on Gene Expression—
Insulin release and rebinding to -cell insulin receptors is
believed to be responsible for the regulation by glucose of sev-
eral genes in this cell type (48–49). To determine whether such
a mechanism may be involved in the regulation of genes
involved in Zn2 homeostasis, we stimulated or blocked insulin
secretion pharmacologically using the KATP channel modula-
tors tolbutamide or diazoxide, respectively. The latter agent
opens KATP channels and thus prevents cell depolarization, ele-
vation in cytosolic Ca2, and, therefore, insulin secretion (50).
Pancreatic islets were incubated for 1 h at 3 mM glucose before
further incubation with either 3 or 16.7 mM glucose for 24 h in
the presence (or absence) of tolbutamide (51) or diazoxide (52).
Despite showing no significant difference compared with the
control case (supplemental Fig. 1), incubationwith tolbutamide
abolished the effects of glucose on the expression of Slc39a6-8.
As shown in supplemental Fig. 1, tolbutamide, which promotes
cytosolic Ca2 increases and insulin secretion even in the
absence of glucose metabolism, tended to evoke an increase in
Slc39a6 and Slc39a7 expression even at low glucose concentra-
tions, thereby at least partially mimicking the effects of incuba-
tion in high glucose (supplemental Fig. 1). Similarly, diazoxide
eliminated the effect of the sugar to stimulate Slc39a6 and
B.
FIGURE 2. Effect of elevated glucose concentrations on the expression of
the genes implicated in Zn2 homeostasis in mouse pancreatic islets.
Mouse isletswere incubated for 1hat 3mMglucosebefore incubation for 24h
(A) or 2 h (B) with either 3 mM (white bars) or 16.7 (black bars) glucose. Total
RNA was extracted, and qPCR analysis of Slc39a1–12, Slc30a1–10, Mt-1, and
Mt-2was performed. The mRNA levels were normalized to those of a house-
keeping gene (cyclophilin A). Bars represent mean S.E. (n 4). *, p 0.05.
FIGURE 3. Effect of elevated glucose concentrations on the expression of
proteins implicated in Zn2 homeostasis in mouse pancreatic islets.
A, total cell lysateswere loadedonto12%SDS-PAGE,whichwas subsequently
transferred onto a PVDF membrane (see “Experimental Procedures”). The
membrane was blotted for ZiP6 (1:200), ZiP7 (1:200), and -tubulin (1:1000)
andwith an HRP-lined anti-rabbit (1:5000) secondary antibody. B, quantifica-
tion of three different immunoblot analyses for ZiP6 and ZiP7. The same area
of interest was drawn around the specific bands for ZiP, ZiP7 as well as the
corresponding tubulin band, and the intensity was measured using ImageJ
software. The ratio of intensity between ZiP or ZiP7 signals and tubulin were
plotted. *, p 0.05.
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Slc39a7 gene expression (Fig. 7). Diazoxide also tended to
decrease the expression of these genes, compared with the con-
trol case, at high glucose (Fig. 7). Surprisingly, perhaps, metal-
lothionein gene expression was unchanged in the presence of
either of these pharmacological agents. Slc39a8 expression was
strongly up-regulated in the presence of diazoxide in combina-
tion with high glucose (Fig. 7).
Effect of Diazoxide on Cellular Stress and Free [Zn2]cyt—Be-
cause Slc39a8was very strongly up-regulated in the presence of
high glucose plus diazoxide, we questioned whether this was due
to an increase in cellular oxidative stress. Thioredoxin-interactin
protein TxNIP participates in the control of the redox state of the
cell by inhibiting thioredoxin (53) andhas been identified as oneof
themost glucose-inducible genes in human and rodent islets (54).
Wethereforemeasured the levelsofTxNIPexpression inresponse
to glucose in the presence or absence of diazoxide. As expected
(54) and shown in Fig. 8A, high glucose increased the level of
TxNIP expression by about 3.3-fold. However, when islets were
incubated with high glucose in the presence of diazoxide, the
expression of TxNIP was 25 times higher than in control condi-
FIGURE 4. Effect of extracellular Zn2 on [Zn2]cyt and on the expression of Slc39a6, Slc39a7, Slc39a8,Mt-1, andMt-2. A, dissociated mouse islets were
infectedwith eCALWY-4-expressing adenovirus and subsequently incubated for 24 h inmedium containing 16.7mM glucose or 3mM glucosewith or without
50 M ZnCl2 before imaging on an Olympus IX microscope. [Zn
2]cyt was calculated as described under “Results” and in the legend to Fig. 1. Bars represent
meanS.E. Thenumberof cells imaged (n) on threedifferentdaysof experiments is given inbrackets under eachbar. **,p0.01; ***,p0.001.B,mouse islets
were incubated for 1 h at 3 mM glucose before culture at either 3, 10, or 16.7 mM glucose for 24 h in the presence (black bars) or absence (white bars) of 50 M
ZnCl2. qPCR analysis of Slc39a6, Slc39a7, Slc39a8, Mt-1, and Mt-2 was performed. Values of expression were normalized to that of a housekeeping gene
(cyclophillin A). The fold changes compared with the values obtained at 3mM glucose are plotted. Bars represent mean S.E. (n 4). *, p 0.05; **, p 0.01;
***, p 0.001.
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tions, suggesting an increase in oxidative stress. We then mea-
sured free [Zn2]cyt in the same conditions and found that the
concentrationswere significantly (p0.05)higher in thepresence
of high glucose and diazoxide than in the presence of high glucose
alone (Fig. 8B). These data correlatewith the increased expression
of ZiP8 (Fig. 7) observed in the presence of high glucose and
diazoxide.
DISCUSSION
The overall aim of this study was to test the hypothesis that
glucose may stably regulate the free concentration of Zn2
within the pancreatic -cell and to explore the underlying
mechanisms behind any observed changes. To address the
first point, we generated an adenovirus to express our
recently developed FRET probe for free cytosolic Zn2 (22).
This tool has allowed us, for the first time, to report, with
high selectivity, changes in cytosolic free Zn2 concentra-
tion within primary -cells and to study its regulation by
glucose and other agents. We show that the resting cytosolic
Zn2 concentrations (400 pM) are similar to those we have
recently shown to pertain in clonal INS-1 (832/13) -cells
(22). This value is also in line with measurements made in
FIGURE 5. Effect of an L-type voltage-gated Ca2 channel blocker on glu-
cose-induced [Zn2]cyt increase. Dissociated mouse islets were infected
with eCALWY-4 expressing adenovirus before incubation with 3 or 16.7 mM
glucosewith orwithout 20Mverapamil for 24 hbefore imagingon anOlym-
pus IXmicroscope. [Zn2]cyt was then calculated as explainedunder “Results”
and in Fig. 1. Bars represent mean S.E. The number of cells imaged (n) on
threedifferentdaysof experiments is given inbrackets under eachbar. **,p
0.01; ***, p 0.001.
FIGURE 6. Effect of elevated intracellular cAMP levels on Slc39a6, Slc39a7, Slc39a8,Mt-1, andMt-2 expression.Mouse islets were incubated for 1 h at 3
mM glucose before incubation at either 3,10, or 16.7 mM glucose for 24 h in the presence (black bars) or absence (white bars) of 50 M 3-isobutyl-1-methyl-
xanthine and 10 M forskolin. qPCR analysis of Slc39a6, Slc39a7, Slc39a, Mt-1, and Mt-2 was performed. Values of expression were normalized to that of
cyclophillin A. The fold changes compared with the values at 3 mM glucose were plotted. Bars represent mean S.E. (n 4). **, p 0.01; ***, p 0.001.
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other mammalian cells according to reports by many groups
(55–57) but not others (58–59). Interestingly, we discovered
that [Zn2]cyt substantially and progressively increases in
response to prolonged (24-h) exposure to high glucose levels
in mouse pancreatic -cells. We also show that these
changes begin as early as 2 h after the increase in glucose
concentration, in line with earlier results that demonstrate
Zn2 influx into mouse islet cells over shorter time frames
(up to 15 min) using trappable chemical probes (29). Each of
the above findings is in contrast, however, with earlier
reports by Zalewski et al. (20), who observed a decrease in
intracellular free Zn2 in islet cells in response to the sugar.
However, these earlier measurements were performed using
whole islets and a synthetic probe (Zinquin) that localizes, at
least partly, to dense core granules and other membrane-
bound organelles, where the free concentration of the ion
may be much higher than in the cytosol (11). Thus, the
decrease in apparent free Zn2 observed earlier may be due
to confounding factors such as degranulation of the cells in
response to glucose. Interestingly, when we blocked the
L-type Ca2 channel with verapamil, we found that the
increase in free [Zn2]cyt was comparable with that observed
in the presence of high glucose alone, indicating that the flux
of Zn2 via the VGCC plays, in this case, a minor role.
We also found that the increase in cytosolic free Zn2 con-
centration reported with eCALWY-4 was associated with
increased expression of one of the key regulators of intracellular
Zn2homeostasis, namely ZiP6, both at themRNAandprotein
level. Furthermore, we demonstrated an increase in ZiP7 and
ZiP8 mRNA expression, although the lack of a suitable specific
antibody against the latter precluded confirmation of such
change at the protein level. ZiP7 immunoreactivity displayed a
small increase at high glucose concentrations, but upon quan-
tification, these changes were not significant. It should be
emphasized that the analysis of gene expression was performed
on whole pancreatic islets. These structures contain a mixed
cell population (, , 	 and pancreatic polypeptide producing
cells (60)) so that changes in gene expression may conceivably
reflect alterations in any of these cell types. However, given that
-cells represent 60–80%of all islet cells, it is nonetheless likely
that changes in the latter cell type predominate.
In linewith our findings here, ZiP8 overexpression elicited by
tissue necrosis factor- (TNF-) induces an increase in intra-
cellular Zn2, measured with FluoZin-3 in lung epithelial cells
FIGURE 7. Effect of the KATP channel opener diazoxide on gene expression. CD1mouse islets were incubated for 1 h at 3mM glucose before a further 24 h
in the presence of either 3 mM (white bars) or 16.7 mM (black bars) glucose in the presence or absence of 325 M diazoxide. RNA was extracted, and Slc39a6,
Slc39a7, Slc39a8,Mt-1, andMt-2 gene expression was analyzed by qPCR. Values were normalized to the one of cyclophillin A, and the fold changes compared
with control experiments at 3 mM glucose were plotted. Bars represent mean S.E. (n 3). *, p 0.05.
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(61). Moreover, down-regulation of ZiP6 is associated with
diminished free cytosolic Zn2, measured with the synthetic
probe Newport green dichlorofluorescein, in dendritic cells
(62). Both ZiP6 and ZiP8 localize to the plasma membrane of
different cell types (61, 63, 64), although in T-cells (65), ZiP8
staining colocalized with lysosomalmarkers. ZiP7, on the other
hand, is mainly localized to the Golgi apparatus (41), indicating
that the observed increase in cytosolic free Zn2may result not
only from enhanced influx of the ion from the extracellular
space but also to release from (non secretory granule) intracel-
lular compartments.
Surprisingly, perhaps, we did not observe any change in the
expression of ZnT8/Slc30a8, the most abundant zinc trans-
porter expressed in mouse pancreatic -cells (10–11, 26), at
high glucose concentrations, at least at the time points and
under the culture conditions deployed here.Moreover, a recent
report indicated that ZnT3 is expressed in pancreatic -cells
and that its expression increases in response to glucose (66). In
contrast to these earlier findings but in line with Ref. 11, we
failed here to observe detectable expression of theZnT3-coding
gene Slc30a3 or an increase in expression following glucose
stimulation in primary -cells. This might be explained by the
fact that in the study by Smidt et al. (66), 4-week-old BALB/CA
male mice were used, as opposed to the 12-week-old female
CD1 mice used in the present study.
Despite the fact that we were unable to detect any changes at
the protein level, the decrease in mRNA levels observed after
24 h at high glucose concentrations suggested a link between
glucose metabolism and Mt expression.
A protective role for metallothioneins in diabetes has been
suggested earlier from the observation that overexpression of
these proteins in response to Zn2 could attenuate streptozo-
cytin-induced diabetes inmice (67) andmay reflect the fact that
they are able to increase the oxidative defense of pancreatic
-cells. The observation that an elevation in cAMP induces a
decrease inmetallothionein expression suggests that thismight
be the pathway through which glucose modulates Mt expres-
sion in pancreatic -cells. However, such a mechanism would
be in contrast to what is observed in adipocytes, where high
levels of cAMP are correlated with increased metallothionein
expression (68).
A previous study using oligonucleotide microarrays (69) has
shown that Slc39a6 and Mt-1a expression are altered at the
mRNA level in rat islets after 96 h of culture at varying glucose
concentrations, but earlier timepointswere not examined. This
study extends these earlier results and begins to dissect the
intracellular signaling mechanisms that lie behind the glucose-
induced changes in the expression of key regulators of intracel-
lular Zn2 homeostasis in the pancreatic -cell. A model sum-
marizing the changes that we report here is presented in Fig. 9.
Whether altered zinc importer andmetallothionein expression
reflect alterations in the transcription of the corresponding
genes or in mRNA (or protein) stability, or combinations of the
above, were not addressed in this study and will require further
detailed investigation in future.
Nonetheless, our findings implicate an unsuspected role for
cAMP in the control by glucose of Mt-1 and Mt-2 mRNA
expression, whereas an increase in cytosolic (and possibly
nuclear) Zn2 is unlikely to be involved in (and would rather be
expected to antagonize) the regulation by glucose of these
genes. On the other hand, a role for cAMP in the control of
Slc39a6–8 expression by glucose seems unlikely, at least on the
basis of the impact of a single large increase in the concentra-
tions of intracellular cAMP, as achieved here by pharmacolog-
icalmeans.Moreover, our results suggest that glucosemight act
via different mechanisms in each case. Either tolbutamide or
diazoxide (which respectively mimic and reverse the effects of
glucose on intracellular free Ca2, thus affecting insulin secre-
FIGURE 8. Effect of the KATP channel opener diazoxide on [Zn
2]cyt and the expression of the marker of cellular stress, TxNIP. A, mouse islets were
incubated for 24 h in the presence of either 3 or 16.7 mM glucose supplemented (black bars) or not (white bars) with 325 M diazoxide before RNA extraction
and analysis of TxNIP gene expression by quantitative real-time PCR. Valueswere normalized to the one of cyclophillin A, and the fold changes comparedwith
control experiments at 3mMglucosewereplotted.Bars representmean S.E. (n 3). *,p 0.05.B, dissociated isletswere infectedwith eCALWY-4-expressing
adenovirus for 24 h and subsequently incubated for a further 24 h supplemented with 3 or 16.7 mM glucose in the presence or absence of 325 M diazoxide
before imaging on an Olympus IX microscope. [Zn2]cyt was then calculated as explained under “Results” and in the legend to Fig. 1. The number of cells
imaged (n) on three different days of experiments is given in brackets under each bar. *, p 0.05; **, p 0.01; ***, p 0.001.
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tion) block the effects of the sugar on Slc39a6 and Slc39a7,
while exerting no effect on the action of glucose on the Mt-1
andMt-2mRNA level. The former result strongly implies a role
for cytosolic Ca2 increases in the action of the sugar on
Slc39a6 and Slc39a7 expression. Although the effects down-
stream of Ca2 may conceivably be mediated by enhanced
insulin secretion and an autocrine (or paracrine) effect via
-cell insulin receptors (70), future studies will be required to
explore this hypothesis.
Surprisingly, the expression of Slc39a8 increased enor-
mously in the presence of high concentrations of glucose and
diazoxide. In the same conditions, free [Zn2]cyt was signifi-
cantly higher than in the presence of high glucose alone.
Although these findings seem likely to reflect an increase in
oxidative stress, they also indicate that ZiP8might play a pivotal
role in modulating zinc homeostasis in pancreatic -cells. We
know that insulin secretion is correlated with zinc release (10),
whose concentration will then rise locally close to the cell sur-
face (71) and might therefore enter the cell via the L-type Ca2
channel or ZiP proteins on the plasmamembrane. However, in
the presence of diazoxide, KATP channels are open, and there-
fore glucose is unable to stimulate insulin/Zn2 release. Also, in
the same conditions, we failed to observe an increase in the
ZiP6 mRNA level. Despite these observations, we still noticed
an increase in free [Zn2]cyt, which may suggest an important
role forZiP8 in the glucose-induced increases in [Zn2]cyt. ZiP8
has been found to be expressed both at the plasma membrane
and on intracellular organelles, including lysosomes, in other
cell types (65). Although similar analyses have yet to be per-
formed in pancreatic -cells, and we were unable to undertake
an immunocytochemical analysis for ZiP8 because of the lack of
a suitable antibody, we speculate that the increase in cytosolic
Zn2 observed might be due not only to the influx of the ion
from the extracellular space but also to the release from intra-
cellular compartments.
What may be the significance of the glucose-induced in-
crease in cytosolic Zn2 concentrations?Weobserved an initial
increase in Slc39a6-8 and a decrease inMt-1 andMt-2 after just
2 h of exposure to elevated (16.7 mM) glucose, indicating that
the up-regulation of these genes represents a relatively early
event in response to the sugar and may be required for the
enhanced synthesis or storage of insulin under these conditions
(3). Moreover, it has been demonstrated that glucose can pro-
mote, via the polypirimide tract binding protein PTB1, the bio-
genesis of insulin-containing dense-core granules (72). How-
ever, although cells are able to synthesize insulin and other
granule proteins de novo, this is not the case for Zn2. Hence,
the uptake (or reuptake) of Zn2 ions is likely to be required to
maintain adequate intracellular (and, as a consequence, intra-
granular) Zn2 levels. Activation of the machinery required to
achieve this (and, in the case ofmetallothioneins, a deactivation
of that which would oppose the local bioavailability of the ions
through its chelation in the cytosol) would appear to represent
an important system for dealing with the need for enhanced
insulin synthesis, storage, and secretion (Fig. 9). Emphasizing
the importance of granular Zn2, we have recently shown that
mice lacking the granule-specific zinc transporter ZnT8 have
reduced intragranular Zn2, which is associated with defective
insulin crystallization and processing in vivo (11, 73). These
data confirmed previous observations made on a transgenic
mouse bearing a mutant form of proinsulin (His-B10-Asp)
unable to bind Zn2, which showed similar defect in insulin
storage (74). However, if hyperglycemia persists, as in the case
of diabetes, then it is conceivable that elevated cytosolic (and
possibly organellar) Zn2 levels may contribute to failures in
-cell signaling and the acute regulation of insulin release and
might lead to irreversible cell failure or death through apoptosis
(35). Indeed, earlier studies (75) and our own unpublished
observations3 indicate that elevations in intracellular free Zn2
inhibit insulin secretion and lead to enhanced apoptosis.
Although high glucose induces insulin secretion, it also
known to induce oxidative stress, as observed by others (76) and
assessed by us with the measurement of expression of TxNIP.
This change results in the suppression of the reducing activity
of thioredoxin, which is expected in turn to prompt in an
increase in reactive oxygen species generation and will there-
fore contribute further to oxidative stress. Enhanced oxidative
3 M. K. Loder and G. A. Rutter, unpublished data.
FIGURE 9. Proposed model of the effect of glucose on the regulation of
Zn2 homeostasis in pancreatic -cells. Shown are glucose-induced
increases in the levels of ZiP6 and ZiP7, likely to be both at the plasmamem-
brane and intracellularmembranes. ZiP8 levelsmay conceivablybe increased
both on lysosomes and plasma membrane. Metallothionein protein levels
were unchanged at 24 h but seem likely to decrease at later time points
following substantial decrease inMt-1 andMt-2mRNA. Please see theDiscus-
sion for other details. The image was generated using Servier Medical Art.
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stress might then prompt metallothioneins to release bound
Zn2, therefore increasing [Zn2]cyt even more. This, together
with the lowering of metallothionein expression, may further
compromise -cell survival at later time points. Although fur-
ther studies are needed to assess the relative importance of
changes in cytosolic [Zn2] in the short and long term, it seems
reasonable to speculate that tight control of free Zn2 concen-
trations in-cellsmay provide ameans to prevent the decline in
functional -cell mass, which characterizes T2D (77).
Acknowledgment–We thank Prof. L. Huang for kindly providing the
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